Clinical trial Papaldo
A phase II randomized study to verify the Papaldo's hypothesis : the effectiveness of a reduced dosing of G-CSF in chemotherapy-treated patients with a low to moderate risk of febrile neutropenia
| Cancers | |
|---|---|
| Organ | Breast |
| Trial status | Trial closed for recruitment |
| Investigator | |
| Trial type |
Interventional without experimental drug
|
| Phase | Trial phase 2 |
| Academic trial | Oui |
| Sponsor | Institut Jules Bordet |
| BECT Identifier | B079201110979 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT01658956 |
| Inclusion criteria | Adjuvant or neoadjuvant |
| Last update |